All news - Fagron

This is Fagron News & Media All news

New Discoveries Show Genetic Links to Androgenetic Alopecia

New Fagron study makes important discoveries about alopecia

Navigating Acne Care: Solutions for patients undergoing hormone therapy

Acne is a common concern affecting people of all genders, but it can present unique challenges for transgender individuals undergoing hormone therapy. As we strive to promote inclusivity and support for all, it’s essential to address the specific needs of transgender patients in managing acne aggravated by hormonal changes. According to recent research, transgender individuals … Continued

Pentravan®: Transforming Gynecological Treatment for Women’s Wellness

Women’s health focuses on women’s unique health needs and concerns throughout their lifespan. It covers a broad range of medical, physical, mental, and social aspects unique to women. Key areas of focus include menstrual disorders, infections, infertility, and hormonal imbalances. Gynecological treatment options Regular check-ups, screenings, and preventive care are crucial for maintaining women’s health. … Continued

The Evolution of Wildlife Veterinary Anesthesia and the Start of Wildlife Pharmaceuticals

Author: Dr. Liesel Laubscher Originally published in Fagron US – Academy. Introduction The inception of veterinary anesthesia dates back to 1836, when Dr. William Sewell of the Royal Veterinary College in London administered curare, a South American arrow poison, to a donkey—a landmark moment in veterinary history. While the donkey survived with intra-tracheal artificial ventilation, … Continued

The Future of Dermocosmetic Treatments

Dermatological skin conditions affect an immense amount of people. They can vary greatly in symptoms and severity, but they all cause distress, and causing a series of impacts on the quality of life. Most common skin conditions Acne, rosacea, dermatitis, and hyperpigmentation are among the most common skin conditions, and they can affect the patient … Continued

Choosing the Right Excipient for Optimal Dosage Form Performance in Immunocompromised Patients

A research recent featured in the Journal of AIDS and HIV Research showed the potential of Low-Dose Naltrexone (LDN) in stabilizing CD4 counts among untreated HIV+ individuals and amplifying CD4 count increments when used alongside antiretroviral therapy. This breakthrough offers promising prospects for advancing HIV management strategies. Compounding of LDN capsules In the realm of … Continued

Technologies that assist in compounding

Compounding pharmacies play a crucial role in the healthcare landscape, offering personalized medication solutions to the unique needs of individual patients. One key aspect that compounding pharmacies address is the concept of reproducibility, ensuring that each compounded medication is consistently and accurately reproduced. The Importance of Reproducibility Reproducibility in compounding pharmacies refers to the ability … Continued

Enhancing Psoriasis Treatment with Advanced Compounding Solutions

Psoriasis, a widespread autoimmune condition, impacts approximately 125 million individuals globally. A majority of psoriasis sufferers, around 80%, experience a milder form of the disease that can be effectively managed using topical treatments. These topical solutions serve various purposes, with different formulations suited for different aspects of the condition. Recent advancements in psoriasis research have … Continued

SyrSpend® SF PH4 NEO has a new brochure!

Fagron’s range of oral suspending vehicles, SyrSpend® SF, offers a solution for different patient groups by providing pharmaceutical stability, dosage consistency, and patient comfort with each preparation. The content was updated to provide you with a better understanding of this specific pediatric subgroup and how SyrSpend® SF PH4 NEO can facilitate their personalized treatment. One of the most important … Continued

Library: A repository for all Fagron-related scientific literature

Science is an integral part of Fagron’s identity and our approach to product development. As an organization, we are committed to remaining the leader in scientific production within the field of pharmaceutical compounding, by generating an unrivaled number of peer-reviewed studies published in prestigious journals around the world. To facilitate access to our scientific literature, … Continued